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ABSTRACr Fragments of phage T7 DNA have been cloned
in Escherichia coli by using the plasmid pMB9. Such cloned
fragments are able to recombine with infecting phages, thus
providing a means to integrate the physical and genetic maps
of 17 DNA. Approximately. 65% of the 17 DNA molecule has
been found in clones so far, and analysis of these clones has
mapp genes 12-17 with an accuracy of about 1% the total
length of T7 DNA. At least some cloned segments can supply 17
functions to infecting phages.
Molecular cloning of DNA is a powerful tool for analyzing the
structure and function of both prokaryotic and eukaryotic
DNAs, and for amplifying specific gene products (1). We are
applying molecular cloning techniques to the analysis of phage
T7 DNA in order to refine the structural and genetic map of
T7 DNA and to explore the usefulness of these techniques for
studying the biochemical relationships between T7 and its host.
T7 DNA is well suited for such analysis because most T7 genes
have been identified and mapped genetically, and a well-
characterized collection of mutants is available (2, 3).
MATERIALS AND METHODS
Phage and Bacterial Strains. Wild-type T7, T7 mutants,
9Escherichia coli B, suppressing strain E. coli 011' (Su+), and E.
colh 011U1 have been described previously (2, 4). The Su-
recipient for transformations, E. coli HMS174 (rK12 mKl2+
recAl rifR Su-), was derived from the E. coil K-12 strains
W31 10 (thy-) and KLL6-99 (5). The Su+ recipient was HB101
(rB- mB- pro- galh strR recAl Su+) (6).
Cloning Procedures. Plasmid pmB9 (7) was used as the
cloning vehicle. Fragments of T7 DNA were inserted at the
single EcoRI cleavage site of pBM9 using poly(dA-dT) con-
nectors (8-11). Fragments of T7 DNA were generated either
by cleavage with Hpa I (12) or by shearing the DNA to an av-
erage size of 4% its full length. Shearing was carried out by
stirring a DNA solution (5 ,g/ml in 1 M NaCI/50 mM Tris-
HCl/1 mM EDTA, pH 8) at full speed in a Lourdes homoge-
nizer at 00. The recombinant plasmids were introduced into
recipient bacteria essentially as described by Wensink et al.
(13). The pMB9 plasmid confers resistance to tetracycline, and
this property was used to select transformants. Clones prepared
from Hpa I fragments are designated "HP," those prepared
from shear fragments, "JC."
Recombination and Complementation Tests. Plasmid-
containing bacteria were grown in tryptone broth supple-
mented with the components of M9 medium (2). Overnight
cultures grown in tubes at 370 without shaking were used di-
rectly (0.2 ml per plate) for testing the plating efficiency of T7
mutants. For complementation tests, overnight cultures were
diluted 100-fold into fresh medium and incubated at 370
without shaking for 3.5 hr (108 cells per ml). Infective T7 par-
ticles (15 per cell) were added, and incubation was continued
at 370 until lysis. Progeny were titered on E. colt 011' (Su+) and
E. coli B (Su-) to measure the burst size of mutant and wild-
type T7.
Preparation and Analysis of DNA. T7 DNA was prepared
by phenol extraction of purified phage particles. Plasmid DNA
was prepared, after amplification in the presence of chloram-
phenicol, by gentle lysis of the cells with lysozyme and deter-
gent, followed by centrifugation to remove chromosomal DNA
(14). Further treatments included phenol extraction, ethanol
precipitation, or banding in CsCl gradient containing ethidium
bromide at 200 ,g/ml with subsequent removal of the ethidium
bromide. Heteroduplexes between plasmid and T7 DNA were
formed and analyzed by the method of Davis et al. (15) using
deletion mutants to mark the left end of T7 DNA. Gel elec-
trophoresis was carried out on agarose slab gels (12).
Containment. All procedures were carried out under P1
physical containment with EK1 host-vector as specified by the
National Institutes of Health Guidelines for Recombinant DNA
Research.
RESULTS
Cloning Random Fragments of 17 DNA. T7 is a strictly
virulent phage, and certain portions of T7. DNA carry infor-
mation lethal to the host cell. We sheared wild-type T7 DNA
to fragments of 4% its full length, hoping to separate lethal from
nonlethal regions and thereby to be able to clone a large portion
of the genome. The fragments were inserted in pBM9 using
poly(dA dT) connectors, and a set of 210 tetracycline-resistant
transformants was isolated. More than 80% of the plasmids
contained more DNA than the parental pMB9 plasmid, as an-
alyzed by electrophoresis in 1% agarose gels.
To demonstrate that fragments of T7 DNA were contained
within the plasmids, five different plasmid DNAs that appeared
to have large insertions were isolated and subjected to hetero-
duplex analysis: pJC13, 15, 19, 27, and 32. Each of the five
DNAs formed a heteroduplex with T7 DNA, and the location
of each fragment within full length T7 DNA was determined
(Fig. 1). Each cloned fragment is unique, and at least four
different regions of the T7 DNA molecule are represented in
these five clones.
Recombination with Cloned Fragments of 17 DNA. Re-
combination between a cloned fragment and an infecting phage
Abbreviations: Su+ and Su-, suppressing and nonsuppressing, re-
spectively.
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FIG. 1. Physical map of cloned fragments and T7 genes in T7 DNA. The map ofHpa I fragments is from ref. 12. Identification of cloned Hpa
I fragments is described in the text. Random fragments are positioned on the basis of heteroduplex mapping modified by recombinational analysis
(Fig. 2). Positions for T7 genes 0.3-1.3 are from refs. 12 and 16. Positions for genes 12-17 are from the present work (see text).
can be detected when the infecting phage is a mutant and the
cloned fragment is wild type. If the T7 mutant used for testing
recombination does not grow on the host that carries the cloned
fragment of T7 DNA, recombination between the infecting
phage and a cloned fragment covering the site of the mutation
can be observed directly by the increase in plating efficiency
that results from the production of wild-type recombinants.
This provides a powerful and simple way to map the location
of cloned fragments and to integrate the genetic and physical
maps of T7 DNA.
T7 amber mutants are an ideal type of infecting phage, be-
cause the mutations have been found in most 17 genes and such
phage do not plate efficiently on Su- hosts (2). Heteroduplex
analysis suggested that the cloned fragments of pJC13 and
pJC27 should lie in the gene 16-17 region of the genome, and
that the fragment in pJCl3 should lie entirely within the
fragment in pJC27 (Fig. 1). (Ref. 12 gives a physical map of T7
genes, based on sizes and relative locations of T7 proteins.) As
shown in Table 1, the plating efficiency of a contiguous set of
gene 16 and 17 amber mutants increases 2-5 orders of mag-
nitude when the host contans pJC13 or pJC27 instead of the
parental plasmid pMB9 and, as predicted by the heteroduplex
analysis, the set of mutations covered by pJC13 lies entirely
within the set covered by pJC27. Furthermore, each of the five
cloned fragments that had been mapped by heteroduplex
analysis was found to give wild-type recombinants with a
contiguous set of T7 mutants in the expected region of the ge-
nome (Fig. 2), as expected if a single continuous fragment of
T7 DNA had been cloned in each.
Although the test for increased plating efficiency is a simple
way to map cloned fragments relative to genetic markers, it
may not work for mutations in every gene. Because little if any
of the mutant protein is produced in an Su- host, an increase
in plating efficiency may not be observed if the mutation is in
a gene essential for recombination, or if cells in which wild-type
recombinants can form are unable to produce phage particles.
Therefore, until it is shown that mutants in a particular gene
are able to increase their plating efficiency by recombination
with a cloned fragment, negative results must be confirmed by
testing recombination in an Su+ host. As shown in following
sections, the plating efficiency test has been shown to work for
mutations in genes 4,5,6,8,9,10,11, 12,13,14,15,16,17, and
19 (Fig. 2). Gene 1 mutants are the only ones for which this test
has been shown not to work (see below). No clones that cover
genes 2, 3, 3.5, or 18 have yet been identified.
Mapping of Random Clones by Recombination. The results
above suggested that a simple spot test could be used for rapid
screening of a large population of cloned fragments. Samples
of as many as 45 different phage stocks, representing any por-
tion of the T7 genome, are applied to a lawn of each host strain
to be tested. The pattern of clearing of the spots indicates the
probable location of the cloned fragment, which can then be
checked by direct plating of individual mutants.
Spot tests were used to screen 124 of the random clones of
sheared fragments of T7 DNA, and regions identified by spot
test were then mapped by testing the plating efficiency of in-
dividual amber mutants. Cloned fragments representing parts
of genes 4 and 5, and most of the region between genes 8 and
17, were identified among the random clones. Positions of a
number of these cloned fragments relative to the T7 amber
mutations are given in Fig. 2.
Cloning of Hpa I Fragments of T7 DNA. Having shown
that much of the I7 DNA molecule can be cloned in pMB9, we
turned to cloning fragments of T7 DNA produced by the re-
striction endonuclease Hpa I. Hpa I cuts wild-type T7 DNA
into 19 specific fragments; the size and location of each are
known (Fig. 1). Thus, recombination with cloned Hpa I frag-
ments can give precise information about the physical location
of T7 amber mutations and therefore the T7 genes.
The DNA used for cloning Hpa I fragments was from a de-
letion mutant of T7, C74, that lacks all of gene 0.7 (16). The
deletion eliminates the leftmost Hpa I cleavage site in T7 DNA,
Table 1. Plating efficiency of T7 amber mutants on plasmid-
carrying HMS174 (Su-) strains
Plating efficiency relative to 011' (Su+)
T7 HMS174/ HMS174/ HMS174/
strain pMB9 pJC13 pJC27
Wild type 1 1 1
16-276 11 X 10-6 12 x 10-6 10 x 10-6
16-162 1 x 10-6 1 x 10-6 0.13
16-291 25 x 10-6 0.065 0.17
16-194 2 x 10-6 0.19 0.24
16-325 5 x 10-6 0.25 0.38
17-145 2 X 10-6 0.008 0.02
17-176 8 X 10-6 0.05 0.05
17-290 5 X 10-6 4 X 10-6 0.006
17-267 12 X 10-6 12 X 10-6 0.004
17-8 33 X 10-6 29 X 10-6 49 x 10-6
Position (T7 units)
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and the resulting fusion fragment contains parts of fragments
F and H; the remaining 17 Hpa I fragments of C74 DNA are
the same as those from wild-type DNA. The mixture of frag-
ments produced by cutting C74 DNA with Hpa I was cloned
in pMB9 using poly(dA-dT) connectors, and a set of 152 tetra-
cycline-resistant transformants was isolated. Of the tested
clones, 70% contained more DNA than did the parental pMB9
plasmid.
Clones from the Hpa I digest of T7 DNA were screened by
spot test, and the location of cloned fragmentswas determined
by their ability to increase the plating efficiency of individual
T7 mutants. As described below, Hpa I fragments G, K, E, P,
B, L, M, and J have been identified in this set of clones, plus four
fragments that have not yet been assigned (Fig. 2). We estimate
that 65% of the T7 DNA molecule is represented in the com-
bined Hpa I and random shear clones of Figs. 1 and 2.
Integration of Physical and Genetic Mapping Using
Cloned Hpa I Fragments. A series of adjacent fragments
covering genes 12-17 could be identified as Hpa I fragments
K, E, P, B, L, and M by knowledge of the sizes of the proteins
(3) and amber peptides (unpublished observations) covered by
each fragment (Figs. 1 and 2). With the exception of fragment
M, which was found only twice in the first 100 clones, each of
the above fragments was found relatively frequently. Inte-
gration of the physical and genetic data determines the physical
location of genes 12-17 with an uncertainty of about 1 T7 unit
(Fig. 1).
The only break in the continuous string of amber mutations
covered by the above set of cloned fragments was 17-178, which
appears not to be covered by either L or M. This could indicate
that a small portion at the end of L or M was not included in the
clones tested, but it is also possible that 17-178 carries a secon-
dary mutation that prevents the formation of wild-type re-
combinants with either plasmid.
Cloning of the Right End of Phage T7. Another type of
clone, found at least 10 times in this set of Hpa I clones, covers
both of the available gene 19 mutants and presumably contains
the right end of the T7 DNA, fragment J. These clones are
unusual because they restrict the growth of T7, wild-type phage
giving small plaques at low efficiency. It should be possible to
identify the region of the J fragment responsible for the re-
striction of T7 growth by cloning subfragments of J. It would
be particularly interesting if the critical region is the terminal
repetition of T7 DNA (18).
Clones Carrying Genes Involved in Phage DNA Metabo-
lism. At least 11 representatives of a clone that covers the right
end of gene 6 were also identified in this set of clones. However,
three other types, covering parts of genes 4 and 5, were each
represented only once. Further work will be required to identify
what parts of T7 DNA were carried by these clones, but the
three types found only once might contain only parts of Hpa
I fragments, a minor fraction of the digest. Presumably clones
of these entire fragments are lethal.
Cloning of Fragment G- the Origin of T7 Replication.
Previous work (12) showed that fragment G contains the right
FIG. 2. Location of cloned fragments relative to T7 mutations.
The T7 mutants are described in refs. 2 and 4, and mapping ofcloned
fragments was based on ability to recombine with infecting phages,
as described in the text. Gene 7 mutants are able to grow on E. coli
K-12 strains (17), including E. coli HMS174. Therefore recombination
of cloned fragments with gene 7 mutants was tested by looking for an
increase in wild-type progeny after growth on the plasmid-carrying
strain rather than by direct plating of gene 7 mutants. In this way
pHP8, pJC19, and pJC135 were all shown not to cover-any of the gene
7 mutations.
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end of gene 1, all of gene 1.1, and the left end of gene 1.3, and
that fragment Q contains the right end of gene 1.3. Clones of
fragments G or Q in HMS174 (Su-) could not be detected by
direct plating of phage mutants because gene 1 mutants are too
defective, and gene 1.1 and 1.3 mutants are able to plate on
HMS174. However, gene 1.3 specifies T7 ligase, and gene 1.3
mutants are unable to plate on ligase-deficient hosts (4).
Therefore, plasmids from 48 different clones from the Hpa I
digest were screened for fragments of gene 1.3 by transferring
them to a ligase-deficient host (011'L1) and then testing for
increased plating efficiency of gene 1.3 mutants. Clone 38 was
found to contain fragment G, but no clone containing fragment
Q was identified.
Recombination between the cloned G fragment and gene 1
mutants could not be detected by increased plating efficiency
of gene 1 mutants on HMS174/pHP38, presumably because
gene 1 mutants are too defective to form recombinants and/or
produce progeny [gene 1 specifies the T7 RNA polymerase
(19)]. Confirmation that the cloned fragment is fragment G was
obtained by transferring pHP38 to the Su+ host, HB101, and
testing for recombination between the cloned fragment and
different gene and 1.3 mutants under permissive conditions.
In this test a large increase in the fraction of wild-type T7 in the
progeny indicates that recombination has occurred. As ex-
pected, the cloned fragment covers both the right end of gene
1 and the left end of gene 1.3 (Fig. 2), the entire G fragment.
This plasmid should carry the origin of replication of T7 DNA,
which has been mapped near position 17 in the T7 DNA
(20).
Complementation by Cloned Fragments ofT7 DNA. Those
cloned fragments that cover all of the amber mutations avail-
able for a particular gene (Fig. 2) were tested for their ability
to complement an infecting mutant. The burst size of individual
amber mutants is measured on an Su- host that carries a cloned
fragment of T7 DNA. If the cloned fragment can provide the
function needed by the mutant, the burst size should represent
an appreciable fraction of that observed with wild-type T7.
Such tests show that pHP2 and pJC84 can provide the needed
functions to gene 13 and gene 14 mutants, and that pJC158 can
provide the gene 13 function (Table 2). Mutants that can be
complemented give a burst 35-70% of that given by wild type
in the same strain, and the progeny are amber mutants (wild-
type recombinants making up only 10-25% of the total). On the
other hand, mutants covered by the cloned fragment, but not
complemented by it, show no increase in burst size over that
observed for pMB9 (for example, 14-140 on pJC158 and 15-114
on pHP2 in Table 2). Even mutants that plate with efficiencies
of 0.2 to 0.4, such as 16-194 on HMS174/pJC27 in Table 1, give
no detectable increase in burst size (data not shown).
The observation that the cloned fragment of pJC158 covers
all available gene 14 mutations (Fig. 2), but does not comple-
ment a gene 14 mutant (Table 2), suggests that not quite all of
gene 14 has been cloned in this plasmid. Other cloned frag-
ments that cover all available markers in a gene (Fig. 2), but do
not appear to complement mutants in that gene (data not
given), include pJC106 (gene 5), pJC32, pJC123, and pJC126
(gene 11), and pHP4 (gene 16). The cloned fragment of pJC126
is the only one of these to cover markers in both adjacent outside
genes and, although the lack of complementation by the other
cloned fragments could be explained by the lack of a complete
gene, the lack of complementation by pJC126 is presumably
for some other reason.
As would be expected, the plating efficiency of an amber
mutant on a complementing SuQ host is the same as that on an
Su+ host (Table 3), and the plaques are large and uniform. In
Table 2. Complementation of T7 amber mutants by cloned
fragments of T7 DNA, as measured by burst size in plasmid-
carrying HMS174 (Su-) strains
Burst size on
indicator strain
Host T7 strain Su- Su+
HMS174/pMB9 Wild type 35 46
13-149 <0.01 1.7
14-140 <0.01 1.2
15-114 <0.01 1.2
HMS174/pHP2 Wild type 25 35
13- 149 2.9 25
14-140 1.4 12
15-114 <0.01 1.5
HMS174/pJC84 Wild type 19 21
13-149 2.8 11
14-140 2.0 8.2
15-114 <0.01 1.2
HMS174/pJC158 Wild type 31 32
13- 149 1.4 12
14-140 <0.01 0.6
15-114 <0.01 0.9
Phage obtained after infecting plasmid-carrying strains ofHMS174
were titered on E. coli B (Su-) and E. coli 011' (Su+) in order to de-
termine the number of wild-type and amber progeny. The small ap-
parent burst of amber mutants on HMS174/pMB9 and on other
noncomplementing hosts is probably due to unadsorbed phage. See
Fig. 2 for the location of the cloned fragments carried by these plas-
mids.
contrast, when the cloned fragment covers the amber mutation
but does not complement it, the plaques are variable in size, and
the plating efficiency rarely reaches as high as 0.3 (Tables
1-3).
Complementing hosts would be very useful if they could
serve as helper strains for isolating or propagating mutants that
are completely defective in the complemented gene. However,
recombination between the cloned fragment and the mutant
strain would also be occurring, and there is a danger that
wild-type recombinants would overgrow a plaque. To deter-
mine how serious a problem this might be, we investigated the
composition of plaques made by 13-149 and by 14-140 on
Table 3. Plating efficiency of T7 amber mutants on plasmid-
carrying HMS174 (Su-) strains
Plating efficiency relative to 011' (Su+)
T7 HMS174/ HMS174/ HMS174/ HMS174/
strain pMB9 pHP2 pJC84 pJC158
12-55 2 X 10-5 2 x 10-5 2 x 10-5
12-42 20x 10-5 0.009 20 x 10-5
12-98 80 x 10-5 0.12 50 x 10-5
12-12 1 X 10-5 2 x 10-5 0.3 0.14
13-149 2 x 10-5 1.0 0.9 0.9
13-272 1 x 10-5 1.2 0.7 0.7
13-89 3 x 10-5 1.2 0.8 1.1
14-201 1 x 10-5 1.4 1.1 0.05
14-140 1 X 10-5 1.2 1.4 0.03
14-332 15 X 10-5 1.0 0.9 0.01
14-279 1 X 10-5 1.1 1.0 0.01
14-35 16X 10-5 1.1 1.0 0.01
14-227 9 X 10-5 0.8 0.8 0.003
15-114 2 X 10- 0.006 2 X 10-5 2 X 10-5
15-217 2 X 10-5 2 X 10-5 2 X 10-5 1 X 10-5
Biochemistry: Campbell et al.
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HMS174/pHP2, a complementing host. Two of the largest
plaques made by each mutant were isolated after incubation
at 370 for 2.3 hr, and two more after 3.5 hr. The composition
was analyzed by suspending each plaque in growth medium,
plating out a dilution on the Su+ host, and determining whether
the plaques that grew represented amber mutants (by picking
individual plaques onto a lawn of an Su- host). Amber mutants
represented 11-35% of the phages in the 2.3-hr plaques, and
1-17% in the 3.5-hr plaques, levels high enough to encourage
further exploration of the use of complementing strains as
helpers.
DISCUSSION
Genetic recombination between cloned fragments of T7 DNA
and infecting phage mutants provides a uniquely powerful way
to integrate the genetic and physical maps of T7 DNA. The
availability of a large collection of genetically mapped mutants
of phage T7 makes possible the rapid screening of cloned
fragments, and virtually any degree of resolution should be
attainable simply by cloning and analysis of well-defined
fragments of T7 DNA produced by restriction endonucleas-
es.
Our experiments suggest that Hpa I fragments C, D, and A
cannot be cloned intact, presumably because they carry in-
formation that is lethal to E. coli. This might explain the failure
of our early attempts to clone the large fragments of T7 DNA
produced by Mbo I (12). With an appropriate set of fragments,
it should ultimately be possible to pinpoint all the lethal region
of T7 DNA and perhaps to clone every part of the T7 ge-
nome.
Recombination between cloned fragments of T7 DNA and
infecting phages is apparently due to a T7 recombination sys-
tem. It occurs in recA hosts, but not when the phage mutant
is defective in gene 1, which specifies the RNA polymerase
needed to transcribe most T7 genes. Therefore, it was somewhat
surprising to find that T7 mutants defective in genes 4, 5, or 6,
all of which have been implicated in T7 recombination (21, 22),
were able to recombine with cloned fragments. Apparently
these functions are not absolutely required for recombination
during T7 infection.
Only a few of the recombinant plasmids analyzed here could
have carried entire T7 genes. Certain clones carrying genes 11,
13, or 14 also carried markers from both adjacent genes and
therefore should have contained entire genes. Of these, clones
carrying gene 13, or both genes 13 and 14, produced products
that could be used by infecting mutants, whereas the clone
carrying gene 11 did not. This difference might be explained
if there were a promoter for 17 DNA polymerase ahead of gene
13 but not gene 11. However, previous work (23) has suggested
that promoters for T7 RNA polymerase lie ahead of both gene
11 and gene 13. Other factors that might affect the ability of
a particular cloned gene to complement an infecting mutant
include the number of protein molecules needed for efficient
complementation, how well the T7 gene can be transcribed by
E. coll RNA polymerase, the number of copies of the plasmid
DNA, and whether the plasmid DNA is degraded after infec-
tion.
The availability of cloned fragments of T7 DNA, and their
ability to recombine with and complement infecting phages,
provide several novel opportunities for genetic and biochemical
analysis of T7. An appropriate set of clones would make possible
rapid mapping of new T7 mutants. Mutagenesis could be re-
stricted to a specific region of the T7 DNA by mutagenizing
the cloned fragment and then allowing wild-type T7 to pick
up the mutations by recombination during infection. Com-
plementing hosts might provide the means to isolate and
propagate completely defective strains. Cloned fragments could
serve as model systems for studying phage recombination, the
mechanism by which T7 degrades host DNA but not its own
DNA after infection, the basis for mutual exclusion between
T3 and T7, and the exclusion of superinfecting phages. Plasmids
that contain the origin of T7 DNA replication or the terminal
repetition of T7 DNA are now available and should be ex-
tremely useful in studies involving these two important regions
in the T7 DNA molecule. Finally, if T7 proteins such as DNA
polymerase, DNA ligase, DNA binding protein, gene 4 protein,
and gene 6 exonuclease can be synthesized in the uninfected
host cell, it may be possible to substitute one or more of them
for E. coli counterparts having a similar function, thus pro-
viding a novel approach to studying the role and specificity of
both the T7 and E. coli enzymes.
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